ABSTRACT

The seminal papers of Prentice (1989), Freedman et al. (1992), and Buyse and Molenberghs (1998) have set the scene for a large research line into surrogate

with

marker evaluation methods. The methods that were proposed by these authors were based on the premise that information regarding the surrogate and the true endpoints is available from a single clinical trial. Hence, these methods are collectively referred to as single-trial surrogate evaluation methods. In this chapter, these methods are briefly reviewed.